Antiplatelet Therapy in ACS and PCI

      -Challenges and Future Directions by Dr. Stephen D. Wiviott (2007)

CLEAR PLATELETS Ib

      -A Mechanistic Link Between High Platelet Reactivity, Inflammation Marker Release and Myonecrosis in Patients Undergoing Stenting by Dr. Paul Gurbel, et al.

(Return to Contents)

Oral

Antiplatelets:

      -Aspirin

      -Clopidogrel

      -Elinogrel

      -Prasugrel

      -Thrombin Receptor Antagonism (TRA)

      -Ticagrelor

(Return to Contents)

Parenteral (IV)

Antiplatelets

      -Cangrelor

      -Elinogrel

      -Glycoprotein 2b3a Inhibitors

(Return to Contents)

Who Are We?    Slide Downloading Policy   Financial Disclosure    We Do Not Promote Off Label Product Use    Copyright    Source of Slides    Editorial Policy    Links Policy    Privacy Policy   Access    CME Programs